Wellington Management Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251M | Sell |
|
|||||
|
2025
Q1 | $254M | Sell |
|
|||||
|
2024
Q4 | $303M | Sell |
|
|||||
|
2024
Q3 | $350M | Buy |
|
|||||
|
2024
Q2 | $313M | Buy |
|
|||||
|
2024
Q1 | $247M | Buy |
|
|||||
|
2023
Q4 | $234M | Buy |
|
|||||
|
2023
Q3 | $79.9M | Buy |
|
|||||
|
2023
Q2 | $37.5M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $399K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $236K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $41.2M | Sell |
|
|||||
|
2020
Q2 | $102M | Sell |
|
|||||
|
2020
Q1 | $188M | Sell |
|
|||||
|
2019
Q4 | $407M | Sell |
|
|||||
|
2019
Q3 | $464M | Buy |
|
|||||
|
2019
Q2 | $492M | Buy |
|
|||||
|
2019
Q1 | $612M | Sell |
|
|||||
|
2018
Q4 | $412M | Sell |
|
|||||
|
2018
Q3 | $479M | Buy |
|
|||||
|
2018
Q2 | $385M | Sell |
|
|||||
|
2018
Q1 | $439M | Sell |
|
|||||
|
2017
Q4 | $548M | Sell |
|
|||||
|
2017
Q3 | $579M | Buy |
|
|||||
|
2017
Q2 | $534M | Buy |
|
|||||
|
2017
Q1 | $376M | Buy |
|
|||||
|
2016
Q4 | $287M | Buy |
|
|||||
|
2016
Q3 | $113M | Buy |
|
|||||
|
2016
Q2 | $9.7M | Sell |
|
|||||
|
2016
Q1 | $17.3M | Buy |
|
|||||
|
2015
Q4 | $26.4M | Buy |
|
|||||
|
2015
Q3 | $17.1M | Sell |
|
|||||
|
2015
Q2 | $29.6M | Sell |
|
|||||
|
2015
Q1 | $74.9M | Buy |
|
|||||
|
2014
Q4 | $21.5M | Buy |
|
|||||
|
2014
Q3 | $2.07M | Sell |
|
|||||
|
2014
Q2 | $15.1M | Sell |
|
|||||
|
2014
Q1 | $24M | Sell |
|
|||||
|
2013
Q4 | $26.1M | Buy |
|
|||||
|
2013
Q3 | $6.26M | Buy |
|
|||||
|
2013
Q2 | $1.57M | Buy |
|